FDA User Fee Renewal Should Include Pre-Market Improvements - Industry

Consumer advocates are suggesting FDA request considerably more funding from device companies in the next round of user fee negotiations, but companies are reluctant to foot more of the bill for device reviews without seeing promised improvements in FDA's pre-market program

More from Archive

More from Medtech Insight